Roberta Mancuso
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Irisin hampers β-amyloid-induced microglial inflammation via the miR-451a/TLR4/NLRP3 axis.
Journal: Frontiers in immunology
Published: December 05, 2025
Intensive multidisciplinary rehabilitation modulates serum α-synuclein and miRNA expression in Parkinson's disease: preliminary results of a randomized study.
Journal: Frontiers in cellular neuroscience
Published: December 04, 2025
Serum miR-199a-3p and miR-103a-3p are possible biomarkers for the onset of multiple sclerosis.
Journal: Scientific reports
Published: September 01, 2025
APOE genotypes are associated with the level of naturally occurring antibodies to amyloid-β in patients with Alzheimer's disease.
Journal: Frontiers in aging neuroscience
Published: July 25, 2025
Engineered Glibenclamide-Loaded Nanovectors Hamper Inflammasome Activation in an Ex Vivo Alzheimer's Disease Model-A Novel Potential Therapy for Neuroinflammation: A Pilot Study.
Journal: Biomolecules
Published: June 19, 2025
Circulatory titin and miR-451a are possible sarcopenia biomarkers in elderly people.
Journal: Frontiers in aging
Published: March 04, 2025
Role of Blood P-Tau Isoforms (181, 217, 231) in Predicting Conversion from MCI to Dementia Due to Alzheimer's Disease: A Review and Meta-Analysis.
Journal: International journal of molecular sciences
Published: September 24, 2024
Biomarkers of neural integrity and immunoglobulin genes influence neurodegeneration in Alzheimer's disease.
Journal: Journal of the neurological sciences
Published: March 13, 2024
Special Issue "Epigenetics in Neurodegenerative Diseases".
Journal: International journal of molecular sciences
Published: March 05, 2024
EBV and multiple sclerosis: expression of LMP2A in MS patients.
Journal: Frontiers in neuroscience
Published: February 12, 2024
Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis.
Journal: Neurobiology of disease
Published: October 20, 2023
Glibenclamide-Loaded Nanoparticles Reduce NLRP3 Inflammasome Activation and Modulate miR-223-3p/miR-7-1-5p Expression in THP-1 Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 19, 2023
Last Updated: 09/26/2026